{"id":"ethinylestradiol-dienogest","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Nausea"},{"rate":"5-15","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-10","effect":"Breakthrough bleeding"},{"rate":"5-10","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ethinylestradiol is a synthetic estrogen that inhibits follicle-stimulating hormone (FSH) secretion, while dienogest is a progestin that suppresses luteinizing hormone (LH) and increases cervical mucus viscosity. Together, they prevent ovulation and alter the endometrial environment to reduce pregnancy risk. This combination is also used to treat endometriosis due to dienogest's anti-inflammatory and anti-proliferative effects on ectopic endometrial tissue.","oneSentence":"Ethinylestradiol and dienogest work together as a combined oral contraceptive, suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:29:48.646Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Endometriosis"}]},"trialDetails":[{"nctId":"NCT06396208","phase":"NA","title":"\"Quick-starting\" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-05-01","conditions":"Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile","enrollment":40},{"nctId":"NCT02636972","phase":"","title":"The Progression From Dysmenorrhoea to Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2014-11","conditions":"Dysmenorrhoea, Pelvic Pain, Chronic Pain","enrollment":56},{"nctId":"NCT06145438","phase":"PHASE3","title":"Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2023-09-04","conditions":"Endometriosis Ovary","enrollment":80},{"nctId":"NCT00754065","phase":"PHASE3","title":"To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-09-08","conditions":"Contraception","enrollment":409},{"nctId":"NCT06577974","phase":"NA","title":"Role of Medical Treatment in Endometriosis Patients Undergoing ICSI","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Endometriosis","enrollment":129},{"nctId":"NCT02400801","phase":"NA","title":"Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-06","conditions":"Endometriosis, Infertility","enrollment":166},{"nctId":"NCT06316206","phase":"PHASE4","title":"The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":80},{"nctId":"NCT06324851","phase":"PHASE4","title":"The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2023-01-01","conditions":"Endometrial Polyp, Endometrial Diseases","enrollment":150},{"nctId":"NCT03945513","phase":"PHASE3","title":"A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2019-12-03","conditions":"Contraception","enrollment":1034},{"nctId":"NCT02352090","phase":"PHASE4","title":"Synthetic vs Natural Estrogen in Combined Oral Contraception","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2015-04-01","conditions":"Contraception","enrollment":59},{"nctId":"NCT00280657","phase":"PHASE3","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03-10","conditions":"Acne Vulgaris","enrollment":1326},{"nctId":"NCT04256200","phase":"PHASE2, PHASE3","title":"Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2017-02-07","conditions":"Endometriosis","enrollment":100},{"nctId":"NCT03890042","phase":"NA","title":"Dienogest for Treatment of Adenomyotic Uteri","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-03-01","conditions":"Adenomyosis","enrollment":100},{"nctId":"NCT01266408","phase":"","title":"INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)","status":"COMPLETED","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2010-11-22","conditions":"Contraception","enrollment":82921},{"nctId":"NCT03353857","phase":"PHASE1","title":"Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-11-29","conditions":"Biological Availability","enrollment":68},{"nctId":"NCT01600274","phase":"NA","title":"Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest","status":"COMPLETED","sponsor":"Pharbil Waltrop GmbH","startDate":"2010-01","conditions":"Focus: Bioequivalence","enrollment":20},{"nctId":"NCT04193852","phase":"PHASE1","title":"Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2019-11-09","conditions":"Bioequivalence","enrollment":10},{"nctId":"NCT03172533","phase":"PHASE2","title":"Estrogen Replacement in Anorexia Nervosa","status":"TERMINATED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2016-03-15","conditions":"Anorexia Nervosa","enrollment":11},{"nctId":"NCT03124524","phase":"PHASE4","title":"Treatment Choice in Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Adana Numune Training and Research Hospital","startDate":"2015-01-15","conditions":"Primary Dysmenorrhea","enrollment":99},{"nctId":"NCT02599077","phase":"PHASE2, PHASE3","title":"Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas","status":"SUSPENDED","sponsor":"Fundación Santa Fe de Bogota","startDate":"2015-11","conditions":"Endometriosis","enrollment":50},{"nctId":"NCT01697111","phase":"PHASE3","title":"Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-10","conditions":"Endometriosis","enrollment":312},{"nctId":"NCT00778609","phase":"PHASE3","title":"Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Oral Contraceptive, Headache, Pelvic Pain","enrollment":449},{"nctId":"NCT00909857","phase":"PHASE3","title":"Effect on Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Primary Dysmenorrhea","enrollment":507},{"nctId":"NCT02385448","phase":"PHASE4","title":"Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2015-02","conditions":"Endometriosis","enrollment":144},{"nctId":"NCT00764881","phase":"PHASE3","title":"Effects of SH T00658ID on Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-01","conditions":"Contraception, Libido","enrollment":217},{"nctId":"NCT00471991","phase":"PHASE2","title":"Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-04","conditions":"Oral Contraceptive","enrollment":60},{"nctId":"NCT00302666","phase":"PHASE3","title":"Bleeding Pattern Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Oral Contraceptive","enrollment":1315}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABORTION INDUCED"},{"count":1,"reaction":"CHEST PAIN"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"FOETAL EXPOSURE DURING PREGNANCY"},{"count":1,"reaction":"GASTROSCHISIS"},{"count":1,"reaction":"HERPES ZOSTER"},{"count":1,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"},{"count":1,"reaction":"MUSCULAR WEAKNESS"},{"count":1,"reaction":"OSTEONECROSIS"},{"count":1,"reaction":"PNEUMONIA"}],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ethinylestradiol / Dienogest","genericName":"Ethinylestradiol / Dienogest","companyName":"University of Palermo","companyId":"university-of-palermo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethinylestradiol and dienogest work together as a combined oral contraceptive, suppressing ovulation through hormonal feedback on the hypothalamic-pituitary-ovarian axis. Used for Contraception, Endometriosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}